Monday, November 2, 2015

Cagle and Bermicker: A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care

Philip T. CagleMDEric H. BernickerMD
From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.

No comments:

Post a Comment